Bone Biologics Cash Flow Statement (2016-2017) | BBLG

Cash Flow Statement Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017
Operating Activities
Net Income -12.26M-4.70M-4.22M-4.70M-2.92M1.02M-2.38M-2.77M
Depreciation and Depletion 580.0040.0040.0040.0024.0024.0024.0024.00
Share-based Compensation 0.92M1.01M1.00M1.20M0.51M0.53M0.37M0.21M
Gains from Sales and Divestitures -0.79M
Gains from Investment Securities 6.36M6.36M6.36M-502.0012.74M8.59M0.41M
Non-cash Items 10.79M5.96M5.96M3.42M1.19M
Cash from Operations -2.53M-2.03M-1.51M-1.27M-1.01M-0.83M-0.56M-0.93M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.12M0.16M0.16M1.36M0.52M0.70M0.94M1.17M
Amortization of Deferred Charges 0.03M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Depreciation & Amortization (CF) 580.0040.0040.0040.0024.0024.0024.0024.00
Change in Working Capital
Change in Accured Expenses 0.30M-0.00M-0.15M-0.08M-0.10M0.27M0.31M0.28M
Other Working Capital Changes 0.00M0.03M-0.03M-0.00M0.00M0.00M-0.04M0.06M
Financing Activities
Cash from Financing Activities 5.63M1.20M2.00M1.40M
Additional items
Change in Cash 3.11M-2.03M-1.51M-0.07M0.99M-0.83M0.84M-0.93M
Free Cash Flow -2.53M-2.03M-1.51M-1.27M-1.01M-0.83M-0.56M-0.93M
Net Cash Flow 3.11M-2.03M-1.51M-0.07M0.99M-0.83M0.84M-0.93M